One executive dashboard to turn every risk into an opportunity
Empower the leadership team with consolidated data to monitor and evaluate project performance and development scenarios.
Automated data aggregation & report generation saves valuable time to focus on strategic initiatives.
Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio.
Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.
Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.
Enhance your drug commercialization strategies with the power of data quickly and accurately
i2e’s proprietary forecasting solution, Clairvoyance, helps deliver higher accuracy and reliability in your forecasting across all lifecycle decisions: market entry, access and reimbursement, and supply chain management.
Our forecasting suite for BioPharma distills the most valuable insights for you generated by our best-in-class forecasting engine driven through industry relevant analytics, data, and domain expertise.
Evidence based decision making
Whether it is pricing or lead candidate demand estimation, make evidence-based decisions led by domain relevant data and our proprietary algorithms.
Manage supply chain risks, pre-empt distribution blind spots, and communicate your insights confidently to executive stakeholders through our intuitive forecast communication and interactive BI dashboards.
We help you manage high-volume high-velocity data, customize it and integrate influencing variables such as market and economic trends and reduce data overwhelm and fatigue.
Whether it is dynamic scenario analysis or driving therapeutic innovation, Clairvoyance can accelerate your forecasting accuracy driving growth, value, and revenue.
Improve R&D productivity through our Live innovation Benchmarking Bench to Market
Assess portfolio augmentation opportunities, drive asset prioritization for licensing and other partnering opportunities.
Evaluate market share impact, monitor key competitive threats, assess and augment eNPV.